In recent years, there has been a growing interest in phenolic compounds and their presumed role in the prevention of various degenerative diseases, such as cancer and cardiovascular diseases. Xanthohumol, a prenylated chalcone from hops and beer, is among the phenolic compounds which have received the most attention in recent years. This compound has a range of interesting biological properties that may have therapeutic utility. Based on the health-promoting properties of xanthohumol, the production of a beer enriched in this substance would be of huge interest to the brewing industry, for the benefits this could bring to consumer's health. This paper reviews recent and important data with respect to the health benefits or biological activities of xanthohumol and beer. In addition, an overview of the chemistry and biotechnological aspects of xanthohumol is presented.
RamírezSC, CastroMMB, CarreteroAS, BlancoCC, GutiérrezAF. (2003) Analysis of beer components by capillary electrophoretic methods. Trends in Analytical Chemistry, 22, 440–455.
2.
KratkyR, BuiattiS. (2008) Beer in Health and Disease Prevention. In The chemical nature of flavor in beer, Chapter 7, PreedyVR (Ed). Elsevier Science & Technology, London, UK, 73–84.
3.
GerhäuserC, AltA, HeissE, Gamal-EldeenA, KlimoK, KnauftJ, NeumannI, ScherfHR, FrankN, BartschH, BeckerH. (2002) Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Molecular Cancer Therapeutics, 1, 959–969.
4.
GerhäuserC. (2005) Beer constituents as potential cancer chemopreventive agents. European Journal of Cancer, 41, 1941–1954.
5.
GerhäuserC. (2005) Broad spectrum anti-infective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites. Molecular Nutrition & Food Research, 49, 827–831.
6.
WünderlichS, ZürcherA, BackW. (2005) Enrichment of xanthohumol in the brewing process. Molecular Nutrition & Food Research, 49, 874–881.
7.
De KeukeleireD. (2000) Fundamentals of beer and hop chemistry. Química Nova, 23, 108–112.
8.
GoldammerT. (2008) The Brewers ‘Handbook: the Complete Book to Brewing Beer. Apex Publishers, Virginia, USA, 1–496.
9.
European Brewery Convention (EBC). (2000) Malting Technology – Manual of Good Practice. In The overall process; Raw materials; The processes. Fachverlag Hans Carl, Nürnberg, Germany, 7–48.
10.
GuidoLF, RajendramR, BarrosAA. (2008) Beer in Health and Disease Prevention. In Pitching yeast and beer flavor, Chapter 3, PreedyVR (Ed). Elsevier Science & Technology, London, UK, 22–32.
11.
HoughJS, BriggsDE, StevensR, YoungTW. (1982) Malting and Brewing Science – Volume 2 – Hopped Wort and Beer. Chapman and Hall, New York, USA, 1–387.
12.
U.S. Department of Agriculture, Agricultural Research Service (2003) USDA National Nutrient Database for Standard Reference, Release 16. Nutrient Data Laboratory Homepage: http://www.nal.usda.gov/fnic/foodcomp.
13.
DuarteI, BarrosA, BeltonPS, RighelatoR, SpraulM, HumpferE, GilAM. (2002) High-resolution nuclear magnetic resonance spectroscopy and multivariate analysis for the characterization of beer. Journal of Agricultural and Food Chemistry, 50, 2475–2481.
14.
GrossMGLebrónMR, MarcosA. (2000) Revisión bibliográfica sobre los efectos del consumo moderado de cerveza sobre la salud. Estudio 6. Centro de información “Cerveza y Salud”.
15.
RodriguesJ, AlmeidaP. (2008) Beer in Health and Disease Prevention. In E-2 nonenal and β-damascenone in beer, Chapter 38, PreedyVR (Ed). Elsevier Science & Technology, London, UK, 395–402.
16.
YuJ, VasanthumT, TemelliF. (2001) Analysis of phenolic acids in barley by high-performance liquid chromatography. Journal of Agricultural and Food Chemistry, 49, 4352–4358.
17.
MontanariL, PerrettiG, NatellaF, GuidiA, FantozziP. (1999) Organic and phenolic acids in beer. Lebensmittel-Wissenschaft und-Technologie, 32, 535–539.
18.
GerhäuserC, BeckerH. (2008) Beer in Health and Disease Prevention. In Phenolic compounds in beer, Chapter 12, PreedyVR (Ed). Elsevier Science & Technology, London, UK, 124–144.
19.
MadiganD, McMurroughI, SmythMR. (1994) Determination of proanthocyanidins and catechins in beer and barley by highperformance liquid chromatography with dual-electrode electrochemical detection. Analyst, 119, 863–868.
20.
StevensJF, TaylorAW, ChawsonJE, DeinzerML. (1999) Fate of xanthohumol and related prenylflavonoids from hops to beer. Journal of Agricultural and Food Chemistry, 47, 2421–2428.
21.
StevensJF, TaylorAW, DeinzerML. (1999) Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography – tandem mass spectrometry. Journal of Chromatography A, 832, 97–107.
22.
CehB, KacM, KosirIJ, AbramV. (2007) Relationships between xanthohumol and polyphenol content in hop leaves and hop cones with regard to water supply and cultivar. International Journal of Molecular Sciences, 8, 989–1000.
23.
MagalhãesPJ, DostalekP, CruzJM, GuidoLF, BarrosAA. (2008) The impact of a xanthohumol-enriched hop product on the behavior of xanthohumol and isoxanthohumol in pale and dark beer: a pilot scale approach. Journal of the Institute of Brewing, 114, 246–256.
24.
MagalhãesPJ, GuidoLF, CruzJM, BarrosAA. (2007) Analysis of xanthohumol and isoxanthohumol in different hop products by liquid chromatography-diode array detection-electrospray ionization tandem mass spectrometry. Journal of Chromatography A, 1150, 295–301.
25.
BiendlM, PinzlC. (2008) Hops and Health. In Effects – Efficacy of individual hop components, Chapter 4, German Hop Museum, Wolnzach, Germany, 49–76.
26.
CallemienD, JerkovicV, RozenbergR, CollinS. (2005) Hop as an interesting source of resveratrol for brewers: Optimization of the extraction and quantitative study by liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. Journal of Agricultural and Food Chemistry, 53, 424–429.
27.
StevensJF, PageJE. (2004) Xanthohumol and related prenylflavonoids from hops and beer: to your good health. Phytochemistry, 65, 1317–1330.
28.
De KeukeleireJ, JanssensI, HeyerickA, GhekiereG, CambieJ, Roldán-RuizI, Van BockstaeleE, De KeukeleireD. (2007) Relevance of organic farming and effect of climatological conditions on the formation of α-acids, β-acids, desmethylxanthohumol, and xanthohumol in hop (Humulus lupulus L.). Journal of Agricultural and Food Chemistry, 55, 61–66.
29.
HeeJJ, SamSK, SookKH, JaeSC. (2005) In vitro free radical and ONOO- scavengers from Sophora flavescens. Archives of Pharmacal Research, 28, 534–540.
30.
BiendlM, MethnerFJ, StettnerG, WalkerCJ. (2004) Brewing trials with a xanthohumol-enriched hop product. Brauwelt International, 22, 182–184.
31.
BiendlM, MitterW, PetersU. (2002) Use of a xanthohumol-rich hop product in beer production. Brauwelt International, 20, 39–42.
32.
BackW, ZürcherA, WünderlichS. (2004) Enrichment of xanthohumol in the brewing process. Patent publication number DE10256166 A1.
33.
StettnerG, MethnerFJ, BiendlM. (2003) Use of a new xanthohumol-rich hop product in the brewhouse – fate of xanthohumol during beer production and influence of non specific hop compounds on the bitterness of beer. Proceedings of the European Brewing Convention Congress, Dublin, Verlag Hans Carl Getränke-Fachverlag: Nürnberg, 1383–1389.
BiendlM. (2007) Commercial hop extracts rich in xanthohumol. Proceedings of the Scientific Commission of International Hop Grower's Convention, Germany, 12.
36.
ForsterA, GahrA, KettererM, BeckB, MassingerS. (2002) Xanthohumol in beer – possibilities and limitations of enrichment. Monatsschrift Fur Brauwissenschaft, 55, 184–194.
37.
KondoK. (2004) Beer and health: preventive effects of beer components on lifestyle-related diseases. Biofactors, 22, 303–310.
38.
KristiansenL, GronbaekM, BeckerU, TolstrupJS. (2008) Risk of pancreatitis according to alcohol drinking habits: a population-based cohort study. American Journal of Epidemiology, 168, 932–937.
39.
MantenaSK, KingAL, AndringaKK, EcclestonHB, BaileySM. (2008) Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol – and obesity-induced fatty liver diseases. Free Radical Biology and Medicine, 44, 1259–1272.
40.
PonickiWR, GruenewaldPJ. (2006) The impact of alcohol taxation on liver cirrhosis mortality. Journal of Studies on Alcohol, 67, 934–938.
41.
BongaertsBW, Van den BrandtPA, GoldbohmRA, De GoeijAF, WeijenberMP. (2008) Alcohol consumption, type of alcoholic beverage and risk of colorectal cancer at specific subsites. International Journal of Cancer, 123, 2411–2417.
42.
PelucchiC, GallusS, GaravelloW, BosettiC, La VecchiaC. (2008) Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. European journal of cancer prevention: the official journal of the European Cancer Prevention Organization (ECP), 17, 340–344.
43.
DeandreaS, TalaminiR, FoschiR, MontellaM, Dal MasoL, FalciniF, La VecchiaC, FranceschiS, NegriE. (2008) Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: A case-control study. Cancer Epidemiology Biomarkers and Prevention, 17, 2025–2028.
44.
StrotherWN, LumengL, McBrideWJ. (2008) Acute ethanol effects on local cerebral glucose utilization in select central nervous system regions of adolescent alcohol-preferring (P) and alcohol-nonpreferring (NP) rats. Alcoholism Clinical and Experimental Research, 32, 1875–1883.
45.
AlderaziY, BrettF. (2007) Alcohol and the nervous system. Current Diagnostic Pathology, 13, 203–209.
46.
LiXM, DengY. (2005) Alcohol abuse in the injury of central nervous system. Chinese Journal of Clinical Rehabilitation, 9, 181–183.
47.
HuntgeburthM, ten FreyhausH, RosenkranzS. (2005) Alcohol consumption and hypertension. Current Hypertension Reports, 7, 180–185.
48.
MillerPM, AntonRF, EganBM, BasileJ, NguyenSA. (2005) Excessive alcohol consumption and hypertension: clinical implications of current research. Journal of clinical hypertension (Greenwich, Conn), 7, 346–351.
49.
LangCH, FrostRA, SummerAD, VaryTC. (2005) Molecular mechanisms responsible for alcohol-induced myopathy in skeletal muscle and heart. International Journal of Biochemistry and Cell Biology, 37, 2180–2195.
50.
WannametheeSG, CamargoCA, MansonJE, WillettWC, RimmEB. (2003) Alcohol drinking patterns and risk of type 2 diabetes mellitus among younger women. Archives of Internal Medicine, 163, 1329–1336.
51.
SakutaH, SuzukiT, ItoT, YasudaH. (2007) Beer ethanol consumption and plasma homocysteine among patients with type 2 diabetes. Diabetes Research and Clinical Practice, 78, 202–207.
52.
BeulensJW, de ZoeteEC, KokFJ, SchaafsmaG, HendricksHF. (2008) Effect of moderate alcohol consumption on adipokines and insulin sensitivity in lean and overweight men: a diet intervention study. European Journal of Clinical Nutrition, 62, 1098–1105.
53.
De LuisDA, FernandezN, AllerR, De LuisJ, ArranzM, IzaolaO. (2003) Relation between total homocysteine levels and beer intake in patients with diabetes mellitus type 2. Annals of Nutrition and Metabolism, 47, 119–123.
54.
JugdaohsinghR, O'ConnellMA, SrioanyakornS, PowellJJ. (2006) Moderate alcohol consumption and increased bone mineral density: potential ethanol and non-ethanol mechanisms. Proceedings of the Nutrition Society, 65, 291–310.
55.
TobeH, MurakiY, KitamuraK, KomiyamaO, SatoY, SugiokaT, MaruyamaHB, MatsudaE, NagaiM. (1997) Bone resorption inhibitors from hop extract. Bioscience Biotechnology & Biochemistry, 61, 158–169.
56.
WrightCA, BruhnCM, HeymannH, BamforthCW. (2008) Beer and wine consumers’ perceptions of the nutritional value of alcoholic and nonalcoholic beverages. Journal of Food Science, 73, H8–H11.
57.
SchröderH, MasabeuA, MartiMJ, ColsM, LisbonaJM, RomagosaC, CariónT, VilertE, MarrugatJ. (2007) Myocardial infarction and alcohol consumption: a population-based case-control study. Nutrition, Metabolism and Cardiovascular Diseases, 17, 609–615.
58.
BrennerH, RothenbacherD, BodeG, MärzW, HoffmeisterA, KoenigW. (2001) Coronary heart disease risk reduction in a predominantly beer-drinking population. Epidemiology, 12, 390–395.
59.
MennenLI, CourcyGP, GuillandJC, DucrosV, ZarebskaM, BertraisS, FavierA, HercbergS, GalanP. (2003) Relation between homocysteine concentrations and the consumption of different types of alcoholic beverages: the supplementation with antioxidant vitamins and minerals study. American Journal of Clinical Nutrition, 78, 334–338.
60.
MukamalKJ, ChungH, JennyNS, KullerLH, LongstrethWTJr, MittlemanMA, BurkeGL, CushmanM, PsatyBM, SiscovickDS. (2006) Alcohol consumption and risk of coronary disease in older adults: the cardiovascular health study. Journal of the American Geriatrics Society, 54, 30–37.
AoshimaH, kar HossainJ, KodaH, KisoY. (2008) Beer in Health and Disease Prevention. In Beer and GABA receptors, Chapter 18, PreedyVR (Ed). Elsevier Science & Technology, London, UK, 193–201.
63.
RuitenbergA, van SwietenJC, WittemanJC, MehtaKM, van DuijnCM, HofmanA, BretelerMM. (2002) Alcohol consumption and risk of dementia: the Rotterdam study. Lancet, 359, 281–286.
64.
PetersR, PetersJ, WarnerJ, BeckettN, BulpittC. (2008) Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age and Ageing, 37, 505–512.
65.
González-MuñozMJ, PeñaA, MeseguerI. (2008) Role of beer as a possible protective factor in preventing Alzheimer's disease. Food and Chemical Toxicology, 46, 49–56.
66.
PeñaA, MeseguerI, González-MuñozMJ. (2007) Influence of moderate beer consumption on aluminium toxicokynetics: acute study. Nutricion Hospitalaria, 22, 371–376.
67.
HernánMA, ChenH, SchwarzschildMA, AscherioA. (2003) Alcohol consumption and the incidence of Parkinson's disease. Annals of Neurology, 54, 170–175.
68.
RodriguezRJ, MirandaCL, StevensJF, DeinzerML, BuhlerDR. (2001) Influence of prenylated and nonprenylated flavonoids on liver microsomal lipid peroxidation and oxidative injury in rat hepatocytes. Food and Chemical Toxicology, 39, 437–445.
69.
VinsonJA, MandaranoM, HirstM, TrevithickJR, BoseP. (2003) Phenol antioxidant quantity and quality in foods: beers and the effects of two types of beer on an animal model of atherosclerosis. Journal of Agricultural and Food Chemistry, 51, 5528–5533.
SierksmaA, van der GaagMS, KluftC, HendriksHF. (2002) Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomizes, diet-controlled intervention study. European Journal of Clinical Nutrition, 56, 1130–1136.
TousoulisD, NtarladimasI, AntoniadesC, VasiliadouC, TentolourisC, PapageorgiouN, LatsiosG, StefanadisC. (2008) Acute effects of different alcoholic beverages on vascular endothelium, inflammatory markers and thrombosis fibrinolysis system. Clinical Nutrition, 27, 594–600.
74.
ImhofA, BlagievaR, MarxN, KoenigW. (2008) Drinking modulates monocyte migration in healthy subjects: a randomized intervention study of water, red wine and beer with or without alcohol. Diabetes and Vascular Disease Research, 5, 48–53.
75.
BamforthCW. (2002) Nutritional aspects of beer – a review. Nutrition Research, 22, 227–237.
76.
JainMG, HislopGT, HoweGR, BurchJD, GhadirianP. (1998) Alcohol and other beverage use and prostate cancer risk among Canadian men. International Journal of Cancer, 78, 707–711.
77.
ParkerAS, CerhanJR, LynchCF, ErshowAG, CantorKP. (2002) Gender, alcohol consumption, and renal cell carcinoma. American Journal of Epidemiology, 155, 455–462.
78.
TsuganeS, FaheMT, SasakiS, BabaS. (1999) Alcohol consumption and all-cause and cancer mortality among middle aged Japanese men: seven-year follow-up of the JPHC study Cohort I. Japan Public Health Center. American Journal of Epidemiology, 150, 1201–1207.
79.
NozawaH, YoshidaA, TajimaO, KatayamaM, SonobeH, WakabayashiK, KondoK. (2004) Intake of beer inhibits azoxymethane-induced colonic carcinogenesis in male Fisher 344 rats. International Journal of Cancer, 108, 404–411.
80.
NozawaH, TazumiK, SatoK, YoshidaA, TakataJ, Arimoto-KobayashiS, KondoK. (2004) Inhibitory effects of beer on heterocyclic amine-induced mutagenesis and PhIP-induced aberrant crypt foci in rat colon. Mutation Research, 559, 177–187.
81.
Arimoto-KobayashiS, IshidaR, NakaiY, IdeiC, TakataJ, TakahashiE, OkamotoK, NegishiT, KonumaT. (2006) Inhibitory effects of beer on mutation in the ames test and DNA adduct formation in mouse organs induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Biological & Pharmaceutical Bulletin, 29, 67–70.
82.
HidestrandM, ShankarK, RonisMJ, BadgerTM. (2005) Effects of light and dark beer on hepatic cytochrome P-450 expression in male rats receiving alcoholic beverages as part of total enteral nutrition. Alcoholism, Clinical and Experimental Research, 29, 888–895.
83.
InnesG. (1998) Cost-effectiveness of beer versus red wine for the prevention of symptomatic coronary artery disease. Canadian Medical Association Journal, 159, 1463–1466.
84.
StevensJF, MirandaCL, FreiB, BuhlerDR. (2003) Inhibition of peroxynitrite-mediated LDL oxidation of prenylated flavonoids: the α,β-unsaturated keto functionality of 2′-hydroxychalcones as a novel antioxidant pharmacophore. Chemical Research in Toxicology, 16, 1277–1286.
85.
MirandaCL, StevensJF, IvanovV, McCallM, FreiB, DeinzerML, BuhlerDR. (2000) Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. Journal of Agricultural and Food Chemistry, 48, 3876–3884.
86.
VogelS, HeilmannJ. (2008) Synthesis, cytotoxicity and antioxidative activity of minor prenylated chalcones from Humulus lupulus. Journal of Natural Products, 71, 1237–1241.
87.
VogelS, OhmayerS, BrunnerG, HeilmannJ. (2008) Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and antioxidative activity. Bioorganic and Medicinal Chemistry, 16, 4286–4293.
88.
VincentAM, EdwardsJL, SadidiM, FeldmanEL. (2008) The antioxidant response as a drug target in diabetic neuropathy. Current Drug Targets, 9, 94–109.
89.
GuerreiroS, MonteiroR, MartinsMJ, CalhauC, AzevedoI, SoaresR. (2007) Distinct modulation of alkaline phosphatise isoenzymes by 17β-estradiol and xanthohumol in breast cancer MCF-7 cells. Clinical Biochemistry, 40, 268–273.
90.
MonteiroR, CalhauC, SilvaAO, Pinheiro-SilvaS, GuerreiroS, GärtnerF, AzevedoI, SoaresR. (2008) Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts. Journal of Cellular Biochemistry, 104, 1699–1707.
91.
PanL, BeckerH, GerhäuserC. (2005) Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor-and mitochondrial pathway. Molecular Nutrition & Food Research, 49, 837–843.
92.
GotoK, AsaiT, HaraS, NamatameI, TomodaH, IkemotoM, OkuN. (2005) Enhanced antitumor activity of xanthohumol, a diacylglycerol acyltransferase inhibitor, under hypoxia. Cancer Letters, 219, 215–222.
93.
ColgateEC, MirandaCL, StevensJF, BrayTM, HoE. (2007) Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Letters, 246, 201–209.
94.
VanhoeckeB, DeryckeL, van MarckV, DepypereH, De KeukeleireD, BrackeM. (2005) Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. International Journal of Cancer, 117, 889–895.
95.
MonteghirfoS, TosettiF, AmbrosiniC, StiglianiS, PozziS, FrassoniF, FassinaG, SoveriniS, AlbiniA, FerrariN. (2008) Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation. Molecular Cancer Therapeutics, 7, 2692–2702.
96.
KooJH, KimHT, YoonHY, KwonKB, ChoiII, JungSH, KimHU, ParkBH, ParkJW. (2008) Effect of xanthohumol on melanogenesis in B16 melanoma cells. Experimental and Molecular Medicine, 40, 313–319.
97.
ZanoliP, ZavattiM. (2008) Pharmacognostic and pharmacological profile of Humulus lupulus L. Journal of Ethnopharmacology, 116, 383–396.
98.
KacJ, PlazarJ, MlinaricA, ZeguraB, LahTT, FilipicM. (2008) Antimutagenicity of hops (Humulus lupulus L.): bioassay-directed fractionation and isolation of xanthohumol. Phytomedicine, 15, 216–220.
99.
PlazarJ, FilipicM, GroothuisGM. (2008) Antigenotoxic effect of xanthohumol in rat liver slices. Toxicology in Vitro, 22, 318–327.
100.
DelmulleL, Vanden BergheT, De KeukeleireD, VandenabeeleP. (2008) Treatment of PC-3 and DU145 prostate cancer cells by prenylflavonoids from hop (Humulus lupulus L.) induces a caspase-independent form of cell death. Phytotherapy research, 22, 197–203.
101.
BrackeME, VanhoeckeBW, DeryckeL, BolcaS, PossemiersS, HeyerickA, StevensCV, De KeukeleireD, DepypereHT, VerstraeteW, WilliamsCA, McKennaST, TomarS, SharmaD, PrasadAK, DePassAL, ParmarVS. (2008) Plant polyphenolics as anti-invasive cancer agents. Anti-Cancer Agents in Medicinal Chemistry, 8, 171–185.
102.
LeeSH, KimHJ, LeeJS, LeeIS, KangBY. (2007) Inhibition of topoisomerase I activity and efflux drug transporters’ expression by xanthohumol from hops. Archives of Pharmacal Research, 30, 1435–1439.
103.
MonteiroR, FariaA, AzevedoI, CalhauC. (2007) Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids. Journal of Steroid & Molecular Biology, 105, 124–130.
104.
DelmulleL, BellahcèneA, DhoogeW, ComhaireF, RoelensF, HuvaereK, HeyerickA, CastronovoV, De KeukeleireD. (2006) Antiproliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine, 13, 732–734.
105.
MonteiroR, BeckerH, AzevedoI, CalhauC. (2006) Effect of hop (Humulus lupulus L.) flavonoids on aromatase (estrogen synthase) activity. Journal of Agricultural and Food Chemistry, 54, 2938–2943.
106.
RadovicB, SchmutzlerC, KohrleJ. (2005) Xanthohumol stimulates iodide uptake in rat thyroid-derived FRTL-5 cells. Molecular Nutrition and Food Research, 49, 832–836.
107.
LustS, VanhoeckeB, JanssensA, PhilippeJ, BrackeM, OffnerF. (2005) Xanthohumol kills B-chronic lymphocytic leukemia cells by an apoptotic mechanism. Molecular Nutrition and Food Research, 49, 844–850.
108.
DietzBM, KangYH, LiuG, EgglerAL, YaoP, ChadwickLR, PauliGF, FarnsworthNR, MesecarAD, van BreemenRB, BoltonJL. (2005) Xanthohumol isolated from Humulus lupulus inhibits menadione-induced DNA damage through induction of quinone reductase. Chemical Research in Toxicology, 18, 1296–1305.
109.
ZhaoF, NozawaH, DaikonnvaA, KondoK, KitanakaS. (2003) Inhibitors of nitric oxide production from hops (Humulus lupulus L.). Biological and Pharmaceutical Bulletin, 26, 61–65.
110.
GerhäuserC, AltAP, KlimoK, KnauftJ, FrankN, BeckerH. (2002) Isolation and potential cancer chemopreventive activities of phenolic compounds of beer. Phytochemistry Reviews, 1, 369–377.
111.
MirandaCL, YangYH, HendersonMC, StevensJF, Santana-RiosG, DeinzerML, BuhlerDR. (2000) Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4,5-F]quinoline, mediated by cDNA-expressed human CYP1A2. Drug Metabolism and Disposition, 28, 1297–1302.
112.
HendersonMC, MirandaCL, StevensJF, DeinzerML, BuhlerDR. (2000) In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica, 30, 235–251.
113.
MirandaCL, AponsoGL, StevensJF, DeinzerML, BuhlerDR. (2000) Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1c1c7 cells. Cancer Letters, 149, 21–29.
114.
MirandaCL, StevensJF, HelmrichA, HendersonMC, RodriguezRJ, YangYH, DeinzerML, BarnesDW, BuhlerDR. (1999) Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food and Chemical Toxicology, 37, 271–285.
115.
PlazarJ, ZeguraB, LahTT, FilipicM. (2007) Protective effects of xanthohumol against the genotoxicity of benzo(a)pyrene (BaP), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and tert-butyl hydroperoxide (t-BOOH) in HepG2 human hepatoma cells. Mutation Research, 632, 1–8.
116.
ChoYC, KimHJ, KimYJ, LeeKY, ChoiHJ, LeeIS, KangBY. (2008) Differential anti-inflammatory pathway by xanthohumol in IFN-γ and LPS-activated macrophages. International Immunopharmacology, 8, 567–573.
117.
NowakowskaZ. (2007) A review of anti-infective and anti-inflammatory chalcones. European Journal of Medicinal Chemistry, 42, 125–137.
TomodaH, OmuraS. (2007) Potential therapeutics for obesity and atherosclerosis: Inhibitors of neutral lipid metabolism from microorganisms. Pharmacology & Therapeutics, 115, 375–389.
120.
CasaschiA, MaiyohGK, RubioBK, LiRW, AdeliK, TheriaultAG. (2004) The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells. Journal of Nutrition, 134, 1340–1346.
121.
HubbardBK, EnyedyI, GilmoreTA, Serrano-WuMH. (2007) Antisense and small-molecule modulation of diacylglycerol acyltransferase. Expert Opinion on Therapeutic Patents, 17, 1331–1339.
122.
MatsudaD, TomodaH. (2007) DGAT inhibitors for obesity. Current Opinion in Investigational Drugs, 8, 836–841.
123.
AlbiniA, Dell'EvaR, VeneR, FerrariN, BuhlerDR, NoonanDM, FassinaG. (2006) Mechanims of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. The Faseb Journal, 20, 527–529.
124.
MojzisJ, VarinskaL, MojzisovaG, KostovaI, MirossayL. (2008) Antiangiogenic effects of flavonoids and chalcones. Pharmacological Research, 57, 259–265.
NoonanDM, BenelliR, AlbiniA. (2007) Angiogenesis and cancer prevention: a vision. Recent results in cancer research, 174, 219–224.
127.
BertlE, KlimoK, HeissE, KlenkeF, PeschkeP, BeckerH, EicherT, HerhausC, KapadiaG, BartschH, GerhäuserC. (2004) Identification of novel inhibitors of angiogenesis using a human in vitro antiangiogenic assay. International Journal of Cancer Prevention, 1, 47–61.
128.
NatarajanP, KattaS, AndreiI, Babu Rao AmbatiV, LeonidaM, HaasGJ. (2008) Positive antibacterial co-action between hop (Humulus lupulus) constituents and selected antibiotics. Phytomedicine, 15, 194–201.
129.
HanskeL, HussongR, FrankN, GerhäuserC, BlautM, BrauneA. (2005) Xanthohumol does not affect the composition of rat intestinal microbiota. Molecular Nutrition and Food Research, 49, 868–873.
130.
BhattacharyaS, ViraniS, ZavroM, HaasGJ. (2003) Inhibition of Streptococcus mutans and other oral streptococci by hop (Humulus lupulus L.) constituents. Economic Botany, 57, 118–125.
131.
AvulaB, GanzeraM, WarnickJE, FeltensteinMW, SufkaKJ, KhanIA. (2004) High-performance liquid chromatographic determination of xanthohumol in rat plasma, urine, and fecal samples. Journal of Chromatographic Science, 42, 378–382.
132.
NookandehA, FrankN, SteinerF, EllingerR, SchneiderB, GerhäuserC, BeckerH. (2004) Xanthohumol metabolites in faeces of rats. Phytochemistry, 65, 561–570.
133.
PossemiersS, HeyerickA, RobbensV, De KeukeleireD, VerstraeteW. (2005) Activation of proestrogens from hops (Humulus lupulus L.) by intestinal microbiota; conversion of isoxanthohumol into 8-prenylnaringenin. Journal of Agricultural and Food Chemistry, 53, 6281–6288.
134.
WangQ, DingZH, LiuJK, ZhengYT. (2004) Xanthohumol, a novel anti-HIV agent purified from hops Humulus lupulus. Antiviral Research, 64, 189–194.
135.
ChattopadhyayD, KhanMT. (2008) Ethnomedicines and ethnomedicinal phytophores against herpesviruses. Biotechnology Annual Review, 14, 297–348.
136.
SinghS, MalikBK, SharmaDK. (2007) Targeting HIV-1 through molecular modeling and docking studies of CXCR4: leads for therapeutic development. Chemical Biology and Drug Design, 69, 191–203.
137.
BuckwoldVE, WilsonRJ, NalcaA, BeerBB, VossTG, TurpinJA, BuckheitRW, WeiJ, Wenzel-MathersM, WaltonEM, SmithRJ, PallanschM, WardP, WellsJ, ChuvalaL, SloaneS, PaulmanR, RussellJ, HartmanT, PtakR. (2004) Antiviral activity of hop constituents against a series of DNA and RNA viruses. Antiviral Research, 61, 57–62.
138.
MizobuchiS, SatoY. (1984) A new flavanone with antifungal activity isolated from hops. Agricultural and Biological Chemistry, 48, 2771–2775.
139.
FrölichS, SchubertC, BienzleU, Jenett-SiemsK. (2005) In vitro antiplasmodial activity of prenylated chalcone derivatives of hops (Humulus lupulus) and their interaction with haemin. Journal of Antimicrobial Chemotherapy, 55, 883–887.
140.
GinsburgH, FaminO, ZhangJ, KrugliakM. (1998) Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of actions. Biochemical Pharmacology, 56, 1305–1313.
141.
HerathW, FerreiraD, KhanSI, KhanIA. (2003) Identification and biological activity of microbial metabolites of xanthohumol. Chemical and Pharmaceutical Bulletin, 51, 1237–1240.
142.
NgehJ, AnandV, GuptaS. (2002) Chlamydia pneumoniae and atherosclerosis – what we know and what we don't. Clinical Microbiology and Infection, 8, 2–13.
143.
VirgiliF, ScacciniC, PackerL, RimbachG. (2001) Antioxidants in Food. In Cardiovascular disease and nutritional phenolics.PokornyN, YanishlievaN, GordonM (Ed). Woodhead Publishing Ltd, Cambridge, UK, 87–99.
144.
YangJY, Della-FeraMA, RayalamS, BaileCA. (2007) Effect of xanthohumol and isoxanthohumol on 3T3-L1 cell apoptosis and adipogenesis. Apoptosis, 12, 1953–1963.
145.
PangY, NikolicD, ZhuD, ChadwickLR, PauliGF, FarnsworthNR, van BreemenRB. (2007) Binding of the hop (Humulus lupulus L.) chalcone xanthohumol to cytosolic proteins in Caco-2 intestinal epithelial cells. Molecular Nutrition & Food Research, 51, 872–879.
146.
ShiY, BurnP. (2004) Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nature Reviews Drug Discovery, 3, 695–710.
147.
YangJY, Della-FeraMA, RayalamS, BaileCA. (2008) Enhanced effects of xanthohumol plus honokiol on apoptosis in 3T3-L1 adipocytes. Obesity, 16, 1232–1238.
